Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Grossman

Showing results (31-40 of 171) with videos related to

Pageof 18
Sort By:
CNS Oncology|April 24, 2015
Objective cerebrospinal fluid response to intraventricular rituximab in indolent CNS lymphomaRoy E Strowd, Inas A Abuali, Stuart A Grossman
Cancers|August 31, 2019
BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain TumorsKarisa C Schreck, Stuart A Grossman, Christine A Pratilas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2006
Management of venous thromboembolism in patients with primary and metastatic brain tumorsDavid E Gerber, Stuart A Grossman, Michael B Streiff
Oncology (Williston Park, N.Y.)|November 23, 2006
Cancer pain management in the 21st centuryStuart A Grossman, Erin M Dunbar, Suzanne A Nesbit
Neuro-Oncology|October 21, 2004
Penetration of intra-arterially administered vincristine in experimental brain tumorFrances M Boyle, Susan L Eller, Stuart A Grossman
Cancer|December 13, 2005
Initial response to glucocorticoidsBeela S Mathew, Kathryn A Carson, Stuart A Grossman
Neuro-Oncology|November 13, 2024
Using a pre-radiation window to identify potentially active cytotoxic agents in adults with newly diagnosed glioblastomaDanielle A Bazer, Antonio C Wolff, Stuart A Grossman
Journal of Pain and Symptom Management|December 22, 2009
High outpatient pain intensity scores predict impending hospital admissions in patients with cancerNina D Wagner-Johnston, Kathryn A Carson, Stuart A Grossman
Neuro-Oncology|April 8, 2017
Point/counterpoint: randomized versus single-arm phase II clinical trials for patients with newly diagnosed glioblastomaStuart A Grossman, Karisa C Schreck, Karla Ballman, et al.
Cancer Chemotherapy and Pharmacology|September 15, 2006
Calculated versus measured creatinine clearance for dosing methotrexate in the treatment of primary central nervous system lymphomaDavid E Gerber, Stuart A Grossman, Tracy Batchelor, et al.
Pageof 18

Showing results (31-40 of 171) with videos related to

Sort By:
Pageof 18
CNS Oncology|April 24, 2015
Objective cerebrospinal fluid response to intraventricular rituximab in indolent CNS lymphomaRoy E Strowd, Inas A Abuali, Stuart A Grossman
Cancers|August 31, 2019
BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain TumorsKarisa C Schreck, Stuart A Grossman, Christine A Pratilas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2006
Management of venous thromboembolism in patients with primary and metastatic brain tumorsDavid E Gerber, Stuart A Grossman, Michael B Streiff
Oncology (Williston Park, N.Y.)|November 23, 2006
Cancer pain management in the 21st centuryStuart A Grossman, Erin M Dunbar, Suzanne A Nesbit
Neuro-Oncology|October 21, 2004
Penetration of intra-arterially administered vincristine in experimental brain tumorFrances M Boyle, Susan L Eller, Stuart A Grossman
Cancer|December 13, 2005
Initial response to glucocorticoidsBeela S Mathew, Kathryn A Carson, Stuart A Grossman
Neuro-Oncology|November 13, 2024
Using a pre-radiation window to identify potentially active cytotoxic agents in adults with newly diagnosed glioblastomaDanielle A Bazer, Antonio C Wolff, Stuart A Grossman
Journal of Pain and Symptom Management|December 22, 2009
High outpatient pain intensity scores predict impending hospital admissions in patients with cancerNina D Wagner-Johnston, Kathryn A Carson, Stuart A Grossman
Neuro-Oncology|April 8, 2017
Point/counterpoint: randomized versus single-arm phase II clinical trials for patients with newly diagnosed glioblastomaStuart A Grossman, Karisa C Schreck, Karla Ballman, et al.
Cancer Chemotherapy and Pharmacology|September 15, 2006
Calculated versus measured creatinine clearance for dosing methotrexate in the treatment of primary central nervous system lymphomaDavid E Gerber, Stuart A Grossman, Tracy Batchelor, et al.
Pageof 18